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Abstract
Aquaporin-4 (AQP4) is a water channel expressed at the sarcolemma of fast-twitch skeletal muscle fibers, whose expression
is altered in several forms of muscular dystrophies. However, little is known concerning the physiological role of AQP4 in
skeletal muscle and its functional and structural interaction with skeletal muscle proteome. Using AQP4-null mice, we
analyzed the effect of the absence of AQP4 on the morphology and protein composition of sarcolemma as well as on the
whole skeletal muscle proteome. Immunofluorescence analysis showed that the absence of AQP4 did not perturb the
expression and cellular localization of the dystrophin-glycoprotein complex proteins, aside from those belonging to the
extracellular matrix, and no alteration was found in sarcolemma integrity by dye extravasation assay. With the use of a 2DE-
approach (BN/SDS-PAGE), protein maps revealed that in quadriceps, out of 300 Coomassie-blue detected and matched
spots, 19 proteins exhibited changed expression in AQP4
2/2 compared to WT mice. In particular, comparison of the protein
profiles revealed 12 up- and 7 down-regulated protein spots in AQP42/2 muscle. Protein identification by MS revealed that
the perturbed expression pattern belongs to proteins involved in energy metabolism (i.e. GAPDH, creatine kinase), as well as
in Ca
2+ handling (i.e. parvalbumin, SERCA1). Western blot analysis, performed on some significantly changed proteins,
validated the 2D results. Together these findings suggest AQP4 as a novel determinant in the regulation of skeletal muscle
metabolism and better define the role of this water channel in skeletal muscle physiology.
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Introduction
Aquaporin-4 (AQP4) is the most important water channel of the
neuromuscular system. AQP4 is expressed in skeletal muscle
plasmalemma [1], and in particular in fast-twitch fibers [2], in
which it determines increased water permeability [2]. In a previous
work we hypothesized that AQP4, together with the endothelial
AQP1,allowshighwaterexchangebetweenthebloodandthefibers
in order to regulate volume changes occurring during muscle
activity [2] which may be related to the substantial muscle swelling
and intracellular osmolyte production occurring during exercise [3–
5]. The physiological relevance of this water channel in the skeletal
muscle is supported by the fact that muscle activity modulates
AQP4 expression as it is evident during disuse [6,7].
Importantly, AQP4 expression is compromised in several muscle
diseases, such as in hereditary muscular dystrophies, in which
components of DGC are lost or strongly altered. For example,
AQP4 is strongly reduced in skeletal muscle of Duchenne muscular
dystrophy (DMD) patients [8–11] as well as in the sarcolemma of
the mdx mouse, an animal model of the disease [2,8,9,12].
Moreover, AQP4 down-regulation was observed in human patients
affected by Limb Girdle Muscular Dystrophies (LGMDs) [13], in
which defects in several isoforms of sarcoglycan (SG) occur.
Reduction of AQP4 expression has often been associated to a
marked reduction in a1-syntrophin (a1-syn) level, because of the
close association between them [14,15]. All these findings supported
the idea that AQP4 water channels may be associated to
dystrophin-glycoprotein complex (DGC).
In order to gain better insight into the role of AQP4 in skeletal
muscle, we took advantage of the AQP4-null mouse model [16].
Previous studies performed on the same murine model have shown
that AQP4 plays a pivotal role in modulating astrocytic function
[17,18] and preserving the blood brain barrier [19]. Furthermore,
AQP4 might be involved in the proliferation, survival, migration
and neuronal differentiation of adult neural stem cells (ANSCs)
[20]. However, no investigations have been conducted in skeletal
muscle regarding the effect of the absence of AQP4 on DGC and
other sarcolemma proteins. Thus, the main purpose of the present
study was: a) to evaluate the effect that the lack of AQP4 has on
DGC and ECM expression and localization; and b) to conduct a
more global protein analysis to assess altered protein patterns in
skeletal muscle of AQP4-null mice.
The results presented in this study contribute to a better
understanding of the relationship between AQP4 water channel,
PLoS ONE | www.plosone.org 1 April 2011 | Volume 6 | Issue 4 | e19225the DGC and the ECM, and suggest potential new physiological
roles of this aquaporin in skeletal muscle activity.
Results
DGC expression analysis by immunofluorescence
Several studies have reported that AQP4 is markedly decreased
in muscle fibers from myopathies in which DGC protein expression
is severely compromised, such as DMD and LGMDs [8,9,13]. To
investigate whether the absence of AQP4 affects membrane
association and expression of DGC components, indirect immuno-
fluorescence was performed on transverse cryosections of WT and
AQP4
2/2 quadriceps muscle, a typical example of fast-twitch fiber
skeletal muscle. In addition to the core components of the DGC,
levels of dysferlin and caveolin-3 (cav-3) were also analyzed.
As expected, staining for AQP4 was only detected in WT muscles
(Figure 1). DGC expression was robust in both WT and AQP4
2/2
muscles: levels of SGs (a-, b-, c- and d-SG) and dystroglycans (a-
and b-DG), as well as dystrophin, were virtually identical in terms of
abundance and cellular distribution. Interestingly, a-syntrophin (a-
syn), which was demonstrated to directly interact with AQP4 [15],
did not show alteration in either the expression level or in
sarcolemmal localization in AQP4
2/2 muscle. Distribution of
dysferlin and cav-3, two proteins of pivotal importance in
Figure 1. Immunofluorescent localization of AQP4 and proteins belonging to the DGC complex in WT and AQP4
2/2 quadriceps
muscle. Except for the absence of AQP4 in null mice muscle, all members of the complex are localized uniformly at the sarcolemma. Scale bar: 50 mm.
doi:10.1371/journal.pone.0019225.g001
Protein Alteration in AQP4-Null Mouse Muscle
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absence of AQP4.
Immunofluorescence results suggest that the absence of AQP4
water channels does not compromise the membrane stability
associated to a defective DGC and related protein expression.
EMC protein expression analysis by immunofluorescence
In order to determine whether AQP4 deficiency impairs ECM
organization, immunofluorescence analysis was performed using
antibodies againstproteins belongingtothebasallamina. As shown in
Figure 2, the cellular labeling of a2-laminin (a2-LAMA) and collagen
VI (COLVI) was regularly distributed outside the fibers, just
surrounding the basal lamina, and no differences were found between
WTand AQP4
2/2 muscles.This gives strong indications that AQP4
deficiency did not induce alteration in ECM organization.
Sarcolemmal integrity assay
Loss of the DGC from the sarcolemma causes membrane
instability, which is the primary defect of dystrophin-deficient
muscular dystrophy [21–23]. Damage to the sarcolemma allows
proteins that are normally restricted to the blood serum to move
across the sarcolemma and accumulate in the sarcoplasm. To
further test the functionality of the DGC in AQP4
2/2 mice and to
test whether the absence of AQP4 could improve sarcolemmal
stability, a tracer assay with fluorescent Evans blue dye that binds
albumin in blood serum [23] was performed, using mdx mice as
positive control (Figure 3). Mdx mice showed severe sarcolemmal
fragility marked by Evans blue dye accumulation in numerous
muscle fibers. In contrast, we never observed Evans blue–positive
fibers in AQP4
2/2 tissue nor in WT, excluding that the absence of
AQP4 compromises membrane integrity.
Comparison of 2D Blue Native (BN)/SDS-PAGE protein
maps obtained from WT and AQP4
2/2 quadriceps
muscle
To analyze differences in quadriceps muscle proteins between
WT and AQP4
2/2 mice, 2D BN/SDS-PAGE was performed.
For this purpose, whole muscle proteins were extracted in BN
buffer containing 1% n-dodecyl-b-D-maltoside (DDM) and
subjected to 2D electrophoresis. Figure 4 shows a pair of
representative 2-D gels of quadriceps muscle proteins from WT
and AQP4
2/2 mice. The WT quadriceps protein pattern was
used to create a proteome master map, useful for landmarking and
identifying proteins whose levels change in AQP4
2/2 mice.
Analysis performed on three triplicates of four different prepara-
tions detected more than 300 protein spots and, among them, 19
protein spots were found to be altered (p,0.05 significance level):
12 were found to be up-regulated in AQP4
2/2 muscle, whereas
decreases were found in expression levels of 7 protein spots. These
proteins covered a broad range of molecular weights and
abundance levels, and are denoted in Figure 4 by black arrows
associated to their relative ID number.
Protein identification by Mass Spectrometry (MS)
Protein identification using ESI-IT was attempted for all
proteins having statistically significant changes in relative protein
levels in AQP4
2/2 quadriceps muscle. Table 1 provides protein
identification for 12 protein spots whose levels of expression were
up-regulated and 7 protein spots whose levels of expression were
down-regulated in AQP4
2/2 mice. MS analysis of digested spots
n. 9469, n. 10315 and 10352 did not yield any reliable protein
identification due to low MASCOT scores.
Interestingly, among the 13 proteins identified by MS, 7 were
associated with metabolic responses of the muscle. Oxoglutarate
dehydrogenase (OGDH) is a key component of the Krebs Cycle
and is located in the mitochondrial matrix, where it catalyzes the
decarboxylation of a-ketoglutarate to produce succinyl CoA. The
expression level of OGDH increased 2.35–fold in AQP4
2/2
quadriceps. Levels of adenylosuccinate synthetase (ADSS), which
plays an important role in purine biosynthesis, by catalysing the
GTP-dependent conversion of IMP and aspartic acid to AMP,
increased 3.14–fold in AQP4
2/2 quadriceps. We identified five
enzymes associated with anaerobic metabolism that all showed a
significant decrease in expression in AQP4
2/2 quadriceps. The
level of muscle glycogen phosphorylase (PYGM), which catalyzes
the breakdown of glycogen to glucose-1-phosphate, decreased
0.43–fold in AQP4
2/2 quadriceps. Phosphoglucomutase-2 (Pgm2),
a glycolytic pathway enzyme that catalyzes the conversion of
glucose-1-phosphate toglucose-6-phosphate, decreased0.82–fold in
AQP4
2/2 quadriceps.Glyceraldheyde 3-phosphate dehydrogenase
(GAPDH), which catalyzes the sixth step of glycolysis by the
conversion of glyceraldehyde 3-phosphate to D-glycerate 1,3-
bisphosphate, was 0.73–fold down-regulated in AQP4
2/2 muscle.
Phosphoglycerate mutase 2 (PGAM2), which catalyzes the
interconversion of 2-phospho-D-glycerate and 3-phospho-D-glyce-
rateintheeighthstep ofglycolisis,decreased0.46–foldinAQP4
2/2
muscle. The levels of two spots of muscle creatine kinase (CK-M),
which reversibly catalyze the transfer of phosphate between ATP
and creatine phosphate, decreased 0.26–fold (spot n. 9536) and
0.79–fold (spot n.9616) in AQP4
2/2 muscle.
We found at least three proteins associated with calcium
homeostasis that changed significantly in AQP4
2/2 quadriceps:
Annexin-6 (ANXA6), implicated in many Ca
2+-regulated processes
(e.g.vesicle trafficking, celldivision, apoptosis,calcium signaling,and
growth regulation), decreased 0.3-fold in AQP4
2/2 muscle. Levels
of parvalbumin (PV), a small calcium binding protein strongly
involved in muscle relaxation, increased 3.1–fold in AQP4
2/2
muscle. Sarcoplasmic/endoplasmic reticulum calcium ATPase 1
(SERCA1), which is an ATP-dependent calcium pump responsible,
in part, for the maintenance of low cytoplasmic free calcium
concentrations, was found to be upregulated in two spots: the spot n.
9257 increased 4.48-fold, and the spot n. 10357 increased 2.74-fold.
Figure 2. Immunofluorescence localization of EMC proteins in
WT and AQP4
2/2 quadriceps muscle. a2-laminin and collagen VI
staining was regularly distributed in both WT and AQP4
2/2 muscle
fibers. Scale bar: 50 mm.
doi:10.1371/journal.pone.0019225.g002
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technique can provide rapid information on the number, size,
composition, and relative abundance of complexes that a given
protein forms. Interestingly, the spots corresponding to SERCA1
were horizontally aligned and this means that it is organized in at
least two multiprotein complexes (MPCs) of different size.
Levels of myosin binding protein C, fast-type 2 (MYBP-C2), a
thick filament-associated protein that modulates muscle contrac-
tion, increased 3.6-fold in AQP4
2/2 quadriceps. Valosin-contain-
ing protein (VCP) is implicated in multiple cellular processes,
including cell cycle regulation, nuclear envelope formation, Golgi
biogenesis, and the ubiquitin proteasome system [24]. This protein
was found to be 2.53-fold upregulated in AQP4
2/2 quadriceps.
Eukaryotic translation elongation factor 1a2 (eEF1A2), whose
canonical function is translational elongation, is normally
expressed only in muscle, brain, and heart. The levels of this
protein increased 3.31-fold in AQP4
2/2 muscle.
In silico elaboration of proteomics data: protein-protein
interaction and Gene Ontology (GO) term enrichment
Proteins identified through MS were elaborated in silico for the
identification of likely networks of proteins which proved to be
differentially expressed in the experimental model under analysis.
Criteria for the interpretation of protein-protein interaction maps
include the individuation of the centrality (position in the map) and
degree of the nodes. The degree of a node indicates the number of
Figure 4. Representative 2D BN/SDS-PAGE protein pattern from WT and AQP4
2/2 quadriceps muscle. 2D-gels were stained with
Coomassie blue after a 4–15% gradient BN-PAGE and 4–12% gradient SDS-PAGE. Several protein spots were found to be altered in AQP4
2/2 muscles.
These proteins were subjected to ESI-IT and those identified are indicated with black arrows with their relative protein ID number.
doi:10.1371/journal.pone.0019225.g004
Figure 3. Sarcolemma integrity assay. To examine infiltration of blood serum proteins into damaged muscle fibers, WT, AQP4
2/2 and mdx mice
were intraperitoneally injected with Evans blue dye. Mdx quadriceps displays many Evans blue dye–positive fibers (visualized by red fluorescence),
due to membrane damage. Evans blue dye was minimally detected in muscle from WT and AQP4
2/2 mice, demonstrating that the absence of AQP4
expression did not perturb sarcolemmal integrity. Scale bar: 50 mm.
doi:10.1371/journal.pone.0019225.g003
Protein Alteration in AQP4-Null Mouse Muscle
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relevant ones in interactome networks, as they represent the
fulcrum of multiple signaling pathways, and their positive/
negative modulation could result in alterations of the activities of
their likely interactors. High degree nodes deriving from in silico
elaboration of ‘‘omic’’ data (i.e. proteomics) are thus best suited for
subsequent targeted approaches (e.g. western blot analysis). Upon
interrogation of the String database, the protein-protein interac-
tion map obtained from the analysis (Figure 5) showed a central
high degree node accounting for the glycolytic enzyme GAPDH
and VCP. Three main clusters (groups of highly-interacting
proteins) could be observed, including a group of metabolism-
related proteins in the right portion of the map, skeletal muscle
contraction (upper-left) and ubiquitination (bottom-left). To
determine whether functional classification could be refined and
expanded, FatiGO/Babelomics was used to perform GO term
enrichment for biological and molecular functions and sub-cellular
compartment localization (Table 2).
Although the list of identified proteins only includes a limited
number of entries, GO term enrichment helped elucidate whether
one specific category of biological and/or molecular function was
particularly altered in the experimental model under analysis
(Table 2). The most significant results were obtained for biological
functions, which highlighted the presence of a group of proteins
involved in monosaccharide metabolic process (GO:0005996 -
PGM2,GAPDH,PGAM) and glucose metabolic process (GO:
0006006 - PGM2, GAPDH, PGAM2). As for molecular functions,
proteins identified as being differentially expressed mainly
accounted for phosphotransferase activities (intramolecular trans-
ferase activity (GO:0016866, GO:0016772 – CKM, PGM2,
PGAM2), cofactor binding (GO:0048037 - GAPDH, OGDH,
PYGM, PGAM2) and calcium ion binding (GO: 0005509 - PV,
ATP2A1), the latter group being particularly relevant in muscle
relaxation/contraction. Determination of GO for cellular compo-
nent localization yielded quite predictable results, indicating
muscle-specific localization for most of the proteins of interest:
sarcoplasm and myofibril (GO:0016528, GO:0030016); sarcoplas-
mic reticulum (GO:0016529).
Proteomic validation by immunoblot analysis
2-D immunoblotting with highly specific primary antibodies was
employed to confirm altered expression levels of distinct
quadriceps muscle proteins. Proteins were electrophoretically
separated as described above and then transferred onto PVDF
membrane. Target proteins were chosen upon evaluation of the
proteomics analysis (differential quantitation) and in silico elabora-
tion of the data, through the consideration of a series of criteria
including high degree of nodes, centrality in the groups emerging
from the protein-protein interaction analysis and most relevant
biological/molecular functions. For this purpose, two up-regulated
(PV and VCP) and two down-regulated proteins (GAPDH and
CK-M) in AQP4
2/2 muscle were chosen.
Figure 6 shows the immunoblot results of the above mentioned
proteins, along with a semiquantitative analysis. Concerning core
nodes from Figure 5, results of VCP and GAPDH expression levels
in AQP4
2/2 muscles confirmed the alterations observed by
proteomic analysis, with a 3-fold increase and a 0.48-fold decrease
respectively.
Among the protein spots that were selected for identification,
two corresponded to CK-M and were found to be down-regulated.
Table 1. Differentially expressed protein spots in AQP4
2/2 quadriceps muscle compared to WT.
Spot no.
Theor.
Mw
pI
predict
No. of
peptides
MASCOT
score
NCBI Acc.
number Protein ID
Upregulated
9061 113447 5.81 9 474 gi|148690779 myosin binding protein C, fast-type, isoform CRA_a
9110 117298 6.51 4 206 gi|29145087 Oxoglutarate dehydrogenase
9145 89936 5.14 9 476 gi|55217 valosin-containing protein
9257 110723 5.13 10 651 gi|36031132 sarcoplasmic/endoplasmic reticulum calcium ATPase 1
9450 50507 8.86 6 409 gi|1583965 adenylosuccinate synthetase:ISOTYPE=muscle
9469 N.I.
10315 N.I.
10322 50764 9.11 2 110 gi|6681273 eukaryotic translation elongation factor 1 alpha 2]
10328 11937 5.02 3 183 gi|53819 parvalbumin
10352 N.I.
10357 110723 5.13 14 738 gi|36031132 sarcoplasmic/endoplasmic reticulum calcium ATPase 1
Down-regulated
9200 97681 6.65 26 1564 gi|6755256 muscle glycogen phosphorylase
9275 76751 5.35 10 496 gi|148701560 Annexin A6
9367 63700 6.02 14 855 gi|33416468 Pgm2
9536 43246 6.58 14 937 gi|6671762 Creatine kinase
9616 43246 6.58 9 649 gi|6671762 Creatine kinase
9728 36045 8.44 5 330 gi|6265546 glyceraldehyde-3-phosphate dehydrogenase
9832 28980 8.65 12 748 gi|9256624 phosphoglycerate mutase 2
Only protein spots that were present on every gel (n=4 separate comparisons) and demonstrating changes with significance p,0.05 were accepted as being
differentially expressed. The proteins were identified by ESI-IT and accession numbers are given.
doi:10.1371/journal.pone.0019225.t001
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MPCs, all down-regulated in AQP4
2/2 muscle. The signals
corresponding to spots n. 9536 and n.9616 were found to be about
0.5-fold decreased compared to WT.
The immunoblot result of PV expression was of particular interest:
this protein was found to be up-regulated in AQP4
2/2 quadriceps
muscle, and the relative spot in the 2-DE map, corresponding to n.
10328 (black arrow in Figure 6A), increased the abundance level by
0.3-fold compared to WT. Interestingly, the antibody reaction in WT
muscles revealed the expression of PV in approximately three
different MPCs, whereas only one of them was present in AQP4
2/2
muscles. These results suggest that in WT muscle multiple PV
complexes may exist possibly located in different areas of the fibers.
We can conclude that the analysis of the proteome of the
AQP4
2/2 quadriceps muscle showing differential expression of
protein was correctly portrayed.
Table 2. GO term enrichment.
#Index Term #1v s#2 P-value Pivotal Proteins
Molecular function
1 intramolecular transferase activity (GO:0016866, GO:0016772) 40% vs 0.12% 0.007467 CKM, PGM2, PGAM2,
3 calcium ion binding (GO:0005509) 40% vs 0.34% 0.008142 PV, ANXA6, ATP2A1
2 cofactor binding (GO:0048037) 30.77% vs 1.79% 0.002451 GAPDH, OGDH, PYGM, PGAM2
Biological function
1 monosaccharide metabolic process (GO:0005996) 60% vs 1.02% 0.007606 PGM2,GAPDH,PGAM
2 glucose metabolic process (GO:0006006) 60% vs 0.71% 0.007171 PGM2, GAPDH, PGAM2, PYGM
Cellular component
1 sarcoplasm and myofibril (GO:0016528, GO:0030016) 25% vs 0.17% 0.00883 ATP2A1, PYGM; MYBPC2
2 sarcoplasmic reticulum (GO:0016529) 25% vs 0.16% 0.00883 ATP2A1, PYGM
Significantly (p-value,0.05) up-regulated ontologies (vs the rest of the mouse genome) are reported.
doi:10.1371/journal.pone.0019225.t002
Figure 5. Protein-protein interaction map of the MS-identified proteins. Protein IDs obtained upon MS-based identification of spots of
interest were uploaded to String 8.3 for protein-protein interaction mapping. High degree nodes (GAPDH and VCP) and three main clusters of
proteins (right, bottom-left, upper-left) were individuated.
doi:10.1371/journal.pone.0019225.g005
Protein Alteration in AQP4-Null Mouse Muscle
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The aim of this study was to analyze to what extent the absence
of AQP4 in the sarcolemma affects muscle protein expression and
sarcolemma integrity.
Immunofluorescence data obtained in quadriceps muscles
suggest that the absence of AQP4 does not impair the expression
of the proteins belonging to DGC or their cellular distribution in
myofibers. AQP4 deletion does not alter the expression of the most
important components of ECM. Furthermore, Evans blue analysis
allowed us to determine the absence of major alterations in
sarcolemma integrity in AQP4
2/2 skeletal muscle. Taken together,
these data suggest that the absence of AQP4 in skeletal muscle does
not alter the DGC-ECM scaffold composition of the sarcolemma
and does not result in a dystrophic phenotype. This also indicates
that the alteration of AQP4 expression observed in several forms of
muscular dystrophy are probably not a consequence of a direct
structural interaction of the water channel with DGC proteins.
However, we cannot exclude a functional interaction that could be
influenced by fiber metabolism.
We then decided to conduct a proteomic investigation of the
effects of the absence of AQP4 in skeletal muscle with the aim of
determining a possible altered protein expression pattern using
techniques of BN/SDS-PAGE and peptide mass fingerprinting.
BN/SDS-PAGE allows effective separation of protein species and
complexes from various subcellular origin preparations. In
particular, this technique seems particularly well suited for
separation of transmembrane proteins and proteins with high
isoelectric point values that usually fail to enter the first dimension
of 2D IEF/SDS gels. In fact, among the proteins identified by MS,
four spots correspond to membrane proteins and four proteins
have an isoelectric point value higher than 8.5, probably rendering
their separation by the usual 2D gel separation method difficult
or impossible. These findings allow us to conclude that 2D BN/
SDS-PAGE constitutes an interesting alternative to conventional
two-dimensional electrophoresis, in agreement with recent litera-
ture [25].
By this approach, we found that the most abundant group of
altered proteins in AQP4
2/2 mice is represented by proteins
involved in metabolism (Table 2). Interestingly, down-regulation
of glycolytic enzymes (PYGM, Pgm2, GAPDH and PGAM2 -
GO:0006006) and phosphagen regulatory enzymes (CK-M -
GO:0016772) suggests that there is a strong glycemic imbalance
and, in general, alterations in bioenergetic pathways in AQP4
2/2
muscle. This latter consideration is supported by the increase in
OGDH, the cofactor binding (GO:0048037), in a key enzyme of
oxidative metabolism (GO:0004591) in the Krebs cycle, and in
ADSS, the activity of which is also related to ATP synthesis
through purine metabolism, probably to compensate energy
supply by glycolysis. The production of 2 mol of ATP from
1 mol of metabolized glucose makes glycolysis a less efficient
biochemical pathway as compared to oxidative phosphorylation,
but the high abundance of fast-acting glycolytic enzymes
nevertheless provides a substantial amount of energy for skeletal
muscle contraction. Glycolysis is an absolutely essential metabolic
system during both anaerobic and aerobic conditions. Hence, the
high concentration and the central metabolic position make
expression levels of glycolytic enzymes susceptible to drastic
changes during physiological adaptations or pathological alter-
ations, such those occurring in several myopathies [26] and in
Figure 6. Immunoblotting analysis of proteins altered in AQP4
2/2 muscle. A) Proteins were separated by 2D BN/SDS-PAGE and
immunoblotted using antibodies against the indicated proteins. B) Semi-quantitative densitometric analysis of expression levels of VCP, GAPDH, CK-
M and PV. Note that all alterations had a high statistical significance. (*p,0.05; **p,0.01).
doi:10.1371/journal.pone.0019225.g006
Protein Alteration in AQP4-Null Mouse Muscle
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rearrangement of AQP4 expression is also found. This gives
further support to our original idea [2] that the expression of
AQP4 is associated with the glycolitic metabolism of the fiber and
that its functional role may be linked to response to physiological
needs during muscle fatigue, probably in the regulation of water
homeostasis in response to metabolite production during muscle
contraction. This hypothesis is markedly supported by our
preliminary observation in mice lacking AQP4, showing impaired
activity of skeletal muscle when subjected to both voluntary and
endurance exercises [29].
A set of proteins altered in AQP4
2/2 mice is involved in
calcium homeostasis. In particular, ANXA6 is closely associated in
the selective modulation of the activity of the Ca
2+ channel
involved in its release from sarcoplasmic reticulum (calcium ion
binding - GO: 0005509 in Table 2) [30]. Interestingly, ANXA6
down-regulation is accompanied by an increase in SERCA1
expression levels, which is probably related to the modulation of
the events involved in excitation-contraction coupling (regulation
of muscle contraction – GO:0006937). In addition, up-regulation
in a specific MPC of PV expression in AQP4
2/2 mice confirms
that alteration in Ca
2+ handling occurs, since PV is the most
important soluble protein involved in Ca
2+ buffering during
muscle relaxation. It is worth noting that a qualitative difference in
PV expression levels between WT and AQP4
2/2 mice is
observed, suggesting that a rearrangement in subcellular organi-
zation probably occurs without significant variation in total
amount of protein. It cannot be ascertain whether alterations in
expression levels of proteins described above are directly affecting
muscle contraction, even if MYBP-C2 (myofibril - GO:0030016),
which is a protein belonging to contractile apparatus, was found to
be up-regulated in AQP4
2/2 mice. The altered expression of this
protein could be a response to variations in Ca
2+ buffering.
Therefore, a new function of AQP4 is probably related to its
action on intracellular Ca
2+ dynamics, as also suggested by altered
spontaneous Ca
2+ oscillations observed in ANSCs from AQP4
2/2
mice [20], and more recently, in astrocytic Ca
2+ signaling events
elicited by cerebral edema [31]. Moreover, it is interesting that
alterations found in AQP4
2/2 muscle affected proteins is typically
expressed in skeletal muscle fast-twitch fibers, the same in which
AQP4 is abundantly expressed.
The translational elongation factor eEF1A2 is a guanine-
nucleotide binding protein, which transports aminoacylated tRNA
to the ribosomal A site during protein synthesis. Recent evidences
suggest an important role for eEF1A2 in driving cap-independent
translation of utrophin A in skeletal muscle [32]. Moreover, a
specific interaction with a novel myosin binding protein-C-like
protein has been described [33], suggesting that increased
expression in eEF1A2 in AQP4
2/2 mice might be related to that
observed for MYBP-C2.
VCP is an ATPase involved in a number of cellular activities,
including homotypic membrane fusion, transcription activation,
nuclear envelope reconstruction, post-mitotic organelle reassem-
bly, cell cycle control, apoptosis and endoplasmic reticulum
associated degradation of proteins [34–37]. The latter function
resulted in a cluster of interacting proteins which can be observed
in the bottom-left portion of the map in Figure 5. Although the
great number of functions in which this protein could be involved
make it difficult to rule out a unique effect of the observed VCP
increase in AQP4
2/2 muscle, the protein-protein interaction map
seems to suggest a particular role of VCP over-expression in the
up-modulation of protein-ubiquitination homeostasis. Recent
analyses on tissues from patients suffering from inclusion body
myopathy (IBM) associated with Paget’s disease of the bone and
fronto-temporal dementia (PFD) appear to support this hypothesis
[38]. Indeed, it has been demonstrated that over-expression of two
mutated isoforms of VCP lead to the accumulation of ubiquiti-
nated body inclusions and protein aggregates in patient tissues.
This results in muscle weakness, which is the presenting symptom
in more than half of IBM/PFD patients and an isolated symptom
in 30% of the cases of these multi-system disorders [39]. However,
the consequences of normal VCP over-expression in skeletal
muscles are yet to be fully explored.
In conclusion, no major alterations have been found in DGC,
ECM or sarcolemma integrity in AQP4
2/2 mice as could have
been supposed to occur. Instead, examining expression levels of
structurally or functionally related proteins on a large scale BN/
SDS-PAGE coupled with other biochemical approaches has
provided us with information on which proteins are responsive
to AQP4 deficiency. This study demonstrates that the absence of
AQP4 in skeletal muscle has effects on regulatory trends of
bioenergetic pathways and Ca
2+ handling, without perturbing the
integrity of the sarcolemma, This establishes an important novel
role of AQP4 in the skeletal muscle and gives new evidence about
the relationship between AQP4 expression and skeletal muscle
metabolism, as previously hypothesized by our group [2].
Materials and Methods
Ethics statement
All experiments conformed to international guidelines on the
ethical use of animals and were designed to minimize the number
of animals used and their suffering. Experiments in this study were
approved by the Italian Health Department (Art. 9 del Decreto
Legislativo 116/92).
AQP4
2/2 transgenic mice
AQP4
2/2 mice with a CD1 genetic background were kindly
provided by Dr. Hu (Nanjing Medical University, China). The
generation of this AQP4 null mice model has been previously
reported [16]. The mice used here were bred and genotyped in an
approved facility at the University of Bari. Mice were kept on a
12 h light-dark cycle with food and water ad libitum. Male WT
and AQP4
2/2 mice with a CD1 genetic background, aged 3
months, were used in these experiments.
Chemicals
e-Aminocaproic acid, Imidazole, Tricine, and Ferritin were
from Fluka (St Louis, MO, USA). Acrylamide/bisacrylamide was
from Serva (Heidelberg, Germany). Protease inhibitor cocktail was
purchased from Roche Diagnostics (Indianapolis, IN, USA). All
other chemicals were obtained from Sigma (St Louis, MO, USA).
Antibodies
Rabbit polyclonal antibody against a-syn has been previously
characterized [40]. Rabbit polyclonal anti-PV antibody was
purchased from Synaptic System (Gottingen, Germany). Goat
polyclonal anti-AQP4 and CK-M, rabbit polyclonal anti-VCP and
anti-b-DG, mouse monoclonal anti-cav-3 and anti-a2-LAMA
antibodies were purchased from Santa Cruz Biotechnology (Santa
Cruz, CA, USA). Mouse monoclonal anti-a-DG antibody was
purchased from Upstate Signaling (Lake Placid, USA). Mouse
monoclonal anti-a-, b-, c- and d- SGs, and anti-dysferlin antibodies
were purchased from Novocastra (Newcastle-upon-Tyne, UK).
Mouse monoclonal anti-GAPDH antibody was purchased from
Millipore (Billerica, MA, USA). Mouse monoclonal anti-dystrophin
(MANDYS1) was purchased from Developmental Studies Hybridoma
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from Abcam (Cambridge, MA, USA).
Immunofluorescence
Quadriceps from male CD1 AQP4
2/2 and WT littermates
were dissected from 3-month-old mice. Muscles were rapidly
frozen in liquid nitrogen–cooled isopentane. 8-mm transverse
sections were prepared using a cryostat (CM 1900; Leica) and
stored on positively charged glass slides (Thermo Scientific).
Sections were acclimated to RT for 15 min and blocked using
0.1% gelatin diluted in PBS for 30 min at RT. Sections were then
incubated at RT for 1 h with antibodies to the following proteins
(antibody dilutions are indicated): AQP4 (1:300), dystrophin (1:10),
a-DG (1:100), b-DG (1:300), a-SG (1:50), b-SG (1:100), c-SG
(1:50), d-SG (1:50), cav-3 (1:200), dysferlin (1:100), a-syn (1:1000),
a2-LAMA (1:500), COL VI (1:200). Primary antibodies were
detected by AlexaFluor 488 and 594 anti–rabbit, anti-goat and
anti–mouse (Invitrogen, CA, USA) secondary antibodies diluted at
1:1000. Secondary antibodies were incubated for 1 h at RT. To
preserve the fluorescence signal, sections were mounted in a
medium containing DAPI. The sections were examined with a
Nikon photomicroscope equipped for epifluorescence (DMRXA;
Leica, Heidelberg GmbH, Mannheim, Germany). Digital images
were obtained with a DMX 1200 camera (Nikon, Tokyo, Japan).
Evans blue tracer assay
To test sarcolemmal integrity, mice were injected with 50 mlo f
Evans blue dye (10 mg/ml in 10 mM of sterile phosphate buffer
and 150 mM NaCl, pH 7.4) per 10 g of body weight [23].
Peritoneal cavity injection was performed on 3-month-old
AQP4
2/2, mdx and relative WT mice. 24 h after injection,
quadricepses were excised and mounted as described in the
‘‘Immunofluorescence’’ section. 8-mm transverse sections were
briefly fixed in ice-cold acetone, washed in PBS (10 mM
phosphate buffer and 150 mM NaCl, pH 7.4), and mounted with
a medium containing DAPI. Evans blue–positive myofibers were
observed with a Leica DMRXA photomicroscope equipped for
epifluorescence, and digital images were obtained as previously
described.
Sample preparation
Skeletal muscle was snap frozen in liquid nitrogen and ground
to a fine powder with a mortar and pestle. Pulverized muscle was
added to ice-cold BN Lysis Buffer (e-aminocaproic acid 500 mM,
Imidazole 7.5 mM, EDTA 2 mM, NaCl 12 mM, glycerol 10%,
DDM 1%, PMSF 1 mM) and protease inhibitor cocktail (Roche).
The lysis was performed on ice for 1 h and the samples were then
centrifuged at 22,0006g for 1 h. The protein content of the
supernatant was measured with BCA Protein Assay Kit (BioRad,
Rockford, IL, USA).
2D BN/SDS-PAGE
Two-dimensional BN/SDS-PAGE is a particular electropho-
retic technique for the global analysis of the subunits of complexes
in proteomes [41]. In the first non-denaturing dimension (BN-
PAGE) complexes ranging from few kDa to several MDa are
separated, and their subunits are resolved in the second denaturing
dimension (SDS-PAGE). With this method we are able to detect
proteins with molecular masses between 10 kDa and up to
200 kDa. 2D BN/SDS-PAGE on skeletal muscle proteins was
performed as previously described [6] with some modifications.
Briefly, 250 mg of protein sample was applied on 4–15%
polyacrylamide native gradient gels. The running buffers were
the anode buffer (25 mM Imidazole, pH 7) and the blue cathode
buffer (7.5 mM Imidazole, pH 7, 50 mM Tricine, and 0.02%
CBB G-250). Electrophoresis was performed at 10 mA for
approximately 8 h at 10uC, and stopped when the tracking line
of CBB G-250 dye had left the edge of the gel. The lanes from the
first dimension were cut into individual strips and, if necessary,
frozen at 220uC. The strips were equilibrated in denaturing buffer
(1% SDS and 1% b-mercaptoethanol) for 30 min at room
temperature and placed into a 2D SDS-PAGE of the same
thickness. The second-dimensional separation was performed on
4–12% SDS-polyacrylamide gels and conducted at 50 mA per gel.
At the end of the run, the gel was either Coomassie-stained or
blotted onto a PVDF membrane (Millipore) for Western blot
analysis.
Gel staining and image analysis
The gels were washed in ultrapure distilled water several times,
then incubated overnight in 0.12% colloidal CBB G-250 solution
[42], washed again with ultrapure distilled water until the blue
background disappears. Each stained slab gel was digitized and
processed using the ImageMaster 2D 6.0 software system (GE
Healthcare) to yield a spotlist giving position, shape and density
information for each detected spot. Scanned gel images (three
replicates of each sample) were then analyzed and each 2-D gel
was matched with an appropriate ‘‘master’’ 2-D gel.
In-Gel Digestion
Spots from 2-DE maps of biological interest (P,0.05) were
carefully excised from the gel and subjected to in-gel trypsin
digestion according to Shevchenko et al. [43] with minor modi-
fications. The gel pieces were swollen in a digestion buffer
containing 50 mM NH4HCO3 and 12.5 ng/mL trypsin (modified
porcine trypsin,sequencing grade,Promega,Madison,WI)inan ice
bath. After 30 min, the supernatant was removed and discarded;
then 20 mLo f5 0m MN H 4HCO3 was added to the gel pieces, and
digestion was allowed to proceed overnight at 37uC. The
supernatant containing tryptic peptides was dried by vacuum
centrifugation. Prior to mass spectrometric analysis, the peptide
mixtures were redissolved in 10 mL of 5% formic acid (FA).
Protein identification by Nano-RP-HPLC-ESI-MS/MS
MS procedures were performed as previously described [44].
Peptide mixtures were separated using nanoflow-HPLC system
(Ultimate; Switchos; Famos; LC Packings, Amsterdam, The
Netherlands). A sample volume of 10 mL was loaded by the
autosampler onto a homemade 2 cm fused silica pre-column
(75 mm I.D.; 375 mm O.D) Reprosil C18-AQ, 3 mm (Ammerbuch-
Entringen, DE) at a flow rate of 2 mL/min. Sequential elution of
peptides was accomplished using a flow rate of 200 nL/min and a
linear gradient from Solution A (2% acetonitrile; 0.1% FA) to 50%
of Solution B (98% acetonitrile; 0.1% FA) in 40 min over the
precolumn in-line with a homemade 10–15 cm resolving column
(75 mm I.D.; 375 mm O.D.; Reprosil C18-AQ, 3 mm (Dr. Maisch
GmbH, Ammerbuch-Entringen, Germany). Peptides were eluted
directly into a High Capacity ion Trap HCTplus (Bruker-
Daltonik, Bremen, Germany). Capillary voltage of 1.5–2 kV and
a dry gas flow rate of 10 L/min were used at a temperature of
200uC. The scan range used was from 300 to 1800 m/z. Protein
identification was performed by searching in the National Center
for Biotechnology Information non-redundant database (NCBInr,
version 20081128, www.ncbi.nlm.nih.gov) using the Mascot
program in-house version 2.2 (Matrix Science, London, UK).
The following parameters were adopted for database searches:
taxonomy Mammals; complete carbamidomethylation of cysteines
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61.2 Da, Fragment Mass Tolerance 60.9 Da, missed cleavages
2. For positive identification, the score of the result of
(2106Log(P)) had to be over the significance threshold level
(P,0.05). Even though high MASCOT scores are obtained with
values greater than 60, when proteins were identified by one
peptide only a combination of automated database search and
manual interpretation of peptide fragmentation spectra was used
to validate protein assignments. In this manual verification the
mass error, the presence of fragment ion series and the expected
prevalence of C-terminus containing ions (Y-type) in the high mass
range were all taken into account. Moreover, replicate measure-
ments confirmed the identity of the protein hits.
Protein-protein interaction analysis
Proteins in biological systems seldom work as independent
entities, rather they are placed in widely interacting regulatory
networks. Therefore, the study of protein-protein interactions is a
valid instrument to retrieve biologically relevant insights, through
the individuation of pivotal webs of proteins and their likely main
modulators. Network analysis software, such as String, determines
and makes graphs of unbiased networks, in which gene products
are represented as nodes, and the biological relationship between
two nodes is represented as an edge (line). All edges are supported
by at least one reference from the literature, from a textbook, or
from canonical information stored in the software internal
database. STRING 8.3 software [45] was used to perform
functional annotation through mapping protein interactors to
the experimentally identified protein species. Proteins identified
experimentally were updated in the software along with indica-
tions of the proteomic analysis and the species under investigation
in order to exclude false-positive protein-protein interactions and
functional annotations derived from investigations on other
species. An internal algorithm identifies proteins from the
submitted list in the STRING database and maps them as grey
nodes. White nodes represent predicted interactors upon matching
against the internal database. The confidence interval was set to
0.700 (high confidence), additional white nodes to 20 and network
depth was kept to the minimum value (1), in order to exclude as
many false positive interactions as possible.
GO term enrichment for biological and molecular
functions and cellular component localization
GO term enrichment for biological functions was performed as
previously reported [46], in order to determine whether the
observed inter-group variations affected a functional cluster of
proteins sharing similar biological and molecular functions, or co-
localizing in a sub-cellular compartment. Protein lists were
uploaded to FatiGO/Babelomics 4 [47] software for comparison
of the experimentally obtained dataset against the whole murine
genome. Upon interrogation of the internal database, the software
converted protein entries into a list of GO terms indicating protein
biological and molecular functions, as well as physiological cell
localization, using the corresponding gene-GO association table.
Then, a Fisher’s exact test was used to check for significant over-
representation of GO terms in the submitted dataset against the
remaining ones from the Mus musculus genome.
Western blot analysis
Equal amounts of protein sample were separated by BN/SDS–
PAGE performed as described previously. Membranes with
blotted proteins were incubated with the following primary
antibodies: PV (1:2000), VCP (1:500), GAPDH (1:2000), CK-M
(1:1000). After being washed, membranes were incubated with
anti-mouse, anti-goat and anti-rabbit peroxidase-conjugated
secondary antibodies (Santa Cruz) at a dilution of 1:10000 and
washed again. Reactive proteins were revealed with an enhanced
chemiluminescent detection system (ECL Plus; GE Healthcare,
Buckinghamshire, UK) and visualized on a Versadoc imaging
system (BioRad). Densitometric analysis was performed using
Scion Image software (Frederick, MD, USA).
Statistics
Statistically significant differences were computed using the
Student’s t-test, the significance level being set at p,0.05. Only
proteins with spot volumes consistently different in all replicate gels
were considered differentially expressed.
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